These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

212 related articles for article (PubMed ID: 26407865)

  • 21. The feasibility of the CD271+ and CD271- mesenchymal stromal cell enrichment toward nucleus pulposus-like cells.
    Jezierska-Wozniak K; Barczewska M; Habich A; Wojtacha P; Badowska W; Maksymowicz W; Wojtkiewicz J
    Folia Histochem Cytobiol; 2017; 55(3):114-123. PubMed ID: 28925497
    [TBL] [Abstract][Full Text] [Related]  

  • 22. CD271/p75(NTR) inhibits the differentiation of mesenchymal stem cells into osteogenic, adipogenic, chondrogenic, and myogenic lineages.
    Mikami Y; Ishii Y; Watanabe N; Shirakawa T; Suzuki S; Irie S; Isokawa K; Honda MJ
    Stem Cells Dev; 2011 May; 20(5):901-13. PubMed ID: 21142793
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Cysteamine treatment restores the in vitro ability to differentiate along the osteoblastic lineage of mesenchymal stromal cells isolated from bone marrow of a cystinotic patient.
    Conforti A; Taranta A; Biagini S; Starc N; Pitisci A; Bellomo F; Cirillo V; Locatelli F; Bernardo ME; Emma F
    J Transl Med; 2015 May; 13():143. PubMed ID: 25947233
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Examining the feasibility of clinical grade CD271+ enrichment of mesenchymal stromal cells for bone regeneration.
    Cuthbert RJ; Giannoudis PV; Wang XN; Nicholson L; Pawson D; Lubenko A; Tan HB; Dickinson A; McGonagle D; Jones E
    PLoS One; 2015; 10(3):e0117855. PubMed ID: 25760857
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Distinct mobilization of circulating CD271+ mesenchymal progenitors from hematopoietic progenitors during aging and after myocardial infarction.
    Iso Y; Yamaya S; Sato T; Poole CN; Isoyama K; Mimura M; Koba S; Kobayashi Y; Takeyama Y; Spees JL; Suzuki H
    Stem Cells Transl Med; 2012 Jun; 1(6):462-8. PubMed ID: 23197850
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Comparative analysis of human mesenchymal stem cells from bone marrow and adipose tissue under xeno-free conditions for cell therapy.
    Li CY; Wu XY; Tong JB; Yang XX; Zhao JL; Zheng QF; Zhao GB; Ma ZJ
    Stem Cell Res Ther; 2015 Apr; 6(1):55. PubMed ID: 25884704
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Wound-healing potential of human umbilical cord blood-derived mesenchymal stromal cells in vitro--a pilot study.
    You HJ; Namgoong S; Han SK; Jeong SH; Dhong ES; Kim WK
    Cytotherapy; 2015 Nov; 17(11):1506-13. PubMed ID: 26212609
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Comparison of molecular profiles of human mesenchymal stem cells derived from bone marrow, umbilical cord blood, placenta and adipose tissue.
    Heo JS; Choi Y; Kim HS; Kim HO
    Int J Mol Med; 2016 Jan; 37(1):115-25. PubMed ID: 26719857
    [TBL] [Abstract][Full Text] [Related]  

  • 29. The Human Umbilical Cord Tissue-Derived MSC Population UCX(®) Promotes Early Motogenic Effects on Keratinocytes and Fibroblasts and G-CSF-Mediated Mobilization of BM-MSCs When Transplanted In Vivo.
    Miranda JP; Filipe E; Fernandes AS; Almeida JM; Martins JP; De la Fuente A; Abal M; Barcia RN; Cruz P; Cruz H; Castro M; Santos JM
    Cell Transplant; 2015; 24(5):865-77. PubMed ID: 24480602
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Adventage of mesenchymal stem cells (MSC) expansion directly from purified bone marrow CD105+ and CD271+ cells.
    Jarocha D; Lukasiewicz E; Majka M
    Folia Histochem Cytobiol; 2008; 46(3):307-14. PubMed ID: 19056534
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Direct comparison of the potency of human mesenchymal stem cells derived from amnion tissue, bone marrow and adipose tissue at inducing dermal fibroblast responses to cutaneous wounds.
    Liu X; Wang Z; Wang R; Zhao F; Shi P; Jiang Y; Pang X
    Int J Mol Med; 2013 Feb; 31(2):407-15. PubMed ID: 23228965
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Secretory profiles and wound healing effects of human amniotic fluid-derived mesenchymal stem cells.
    Yoon BS; Moon JH; Jun EK; Kim J; Maeng I; Kim JS; Lee JH; Baik CS; Kim A; Cho KS; Lee JH; Lee HH; Whang KY; You S
    Stem Cells Dev; 2010 Jun; 19(6):887-902. PubMed ID: 19686050
    [TBL] [Abstract][Full Text] [Related]  

  • 33. The role of growth factors in maintenance of stemness in bone marrow-derived mesenchymal stem cells.
    Eom YW; Oh JE; Lee JI; Baik SK; Rhee KJ; Shin HC; Kim YM; Ahn CM; Kong JH; Kim HS; Shim KY
    Biochem Biophys Res Commun; 2014 Feb; 445(1):16-22. PubMed ID: 24491556
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Mesenchymal stromal cells for cutaneous wound healing in a rabbit model: pre-clinical study applicable in the pediatric surgical setting.
    Pelizzo G; Avanzini MA; Icaro Cornaglia A; Osti M; Romano P; Avolio L; Maccario R; Dominici M; De Silvestri A; Andreatta E; Costanzo F; Mantelli M; Ingo D; Piccinno S; Calcaterra V
    J Transl Med; 2015 Jul; 13():219. PubMed ID: 26152232
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Heat shock protein-90 beta is expressed at the surface of multipotential mesenchymal precursor cells: generation of a novel monoclonal antibody, STRO-4, with specificity for mesenchymal precursor cells from human and ovine tissues.
    Gronthos S; McCarty R; Mrozik K; Fitter S; Paton S; Menicanin D; Itescu S; Bartold PM; Xian C; Zannettino AC
    Stem Cells Dev; 2009 Nov; 18(9):1253-62. PubMed ID: 19327008
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Establishing criteria for human mesenchymal stem cell potency.
    Samsonraj RM; Rai B; Sathiyanathan P; Puan KJ; Rötzschke O; Hui JH; Raghunath M; Stanton LW; Nurcombe V; Cool SM
    Stem Cells; 2015 Jun; 33(6):1878-91. PubMed ID: 25752682
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Microencapsulated equine mesenchymal stromal cells promote cutaneous wound healing in vitro.
    Bussche L; Harman RM; Syracuse BA; Plante EL; Lu YC; Curtis TM; Ma M; Van de Walle GR
    Stem Cell Res Ther; 2015 Apr; 6(1):66. PubMed ID: 25889766
    [TBL] [Abstract][Full Text] [Related]  

  • 38. The systemic influence of platelet-derived growth factors on bone marrow mesenchymal stem cells in fracture patients.
    Tan HB; Giannoudis PV; Boxall SA; McGonagle D; Jones E
    BMC Med; 2015 Jan; 13():6. PubMed ID: 25583409
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Cd271 mediates proliferation and differentiation of epidermal stem cells to support cutaneous burn wound healing.
    Zhang M; Cao Y; Li X; Hu L; Taieb SK; Zhu X; Zhang J; Feng Y; Zhao R; Wang M; Xue W; Yang Z; Wang Y
    Cell Tissue Res; 2018 Feb; 371(2):273-282. PubMed ID: 29150821
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Osteogenic potential of heterogeneous and CD271-enriched mesenchymal stromal cells cultured on apatite-wollastonite 3D scaffolds.
    Müller S; Nicholson L; Al Harbi N; Mancuso E; Jones E; Dickinson A; Wang XN; Dalgarno K
    BMC Biomed Eng; 2019 Jun; 1():16. PubMed ID: 32002516
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.